Project Grant R01HL183649
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded The Johns Hopkins University a Project Grant totaling $198,654 under the Cardiovascular Diseases Research program (CFDA 93.837) effective August 1, 2025, through July 31, 2030. This award supports a five-year research initiative investigating the role of diet quality and food insecurity as modifiable factors linking socioeconomic status to Chronic Obstructive Pulmonary Disease (COPD) morbidity and...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded the University of Connecticut Health Center a $293,395 Project Grant (CFDA 93.837: Cardiovascular Diseases Research) effective August 15, 2025, with a completion date of July 31, 2028. This award supports the "Democratizing Access to Cleaner Residential Air" (DACRA) initiative, which investigates the efficacy and feasibility of low-cost Corsi-Rosenthal boxes as an intervention to reduce...
- Federal Project Grant Award Summary The Johns Hopkins University received a $1,070,295 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded August 24, 2025, with completion targeted for June 30, 2030. The research project investigates the role of kynurenine pathway (KP) metabolism in pulmonary arterial hypertension (PAH), a disease characterized by pulmonary vascular remodeling and increased vascular...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) awarded Massachusetts General Hospital a Project Grant of $1,579,554 on September 10, 2025, for research concluding June 30, 2030. The award funds an integrated genomic and functional research initiative to decipher the mechanisms underlying chronic obstructive pulmonary disease (COPD) and asthma—two of the most common and costly chronic respiratory...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded The Johns Hopkins University a Project Grant totaling $120,363 under the Cardiovascular Diseases Research program (CFDA 93.837), effective August 18, 2025, through July 31, 2030. This K24 Mid-Career Investigator Award provides resources, training, and protected time to strengthen and expand Dr. Michelle Eakin's mentoring program focused on patient-oriented implementation science in asthma care. The award...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), awarded the University of Virginia $2.31 million on September 15, 2025, for a project grant extending through May 31, 2029. The award funds development and application of MetaBoxcan, an advanced computational method that integrates genome-wide association studies (GWAS) with metabolomics and gene expression data to identify metabolic pathways...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded Thomas Jefferson University a Project Grant of $234,000 under the Cardiovascular Diseases Research program (CFDA 93.837) for the period September 1, 2025, through August 31, 2027. The award funds a research project titled "Circulating Immunoactive Small RNAs in COPD as Biomarkers," which aims to characterize the expression patterns of novel circulating short non-coding RNAs (sncRNAs) in chronic...
- Federal Project Grant Award Summary The Johns Hopkins University received a $180,488 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective March 1, 2026 through September 15, 2027. This award funds research investigating severe acute respiratory failure (ARF) following immune checkpoint inhibitor (ICI) therapy for cancer treatment. The research will identify clinical and biomarker risk factors...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded The Johns Hopkins University a Project Grant totaling $638,176 effective May 1, 2026, through February 28, 2029, under the Cardiovascular Diseases Research program (CFDA 93.837). This grant funds basic and translational research investigating thrombospondin-1 (TSP-1), a matricellular protein implicated in cardiac fibrosis associated with heart failure with preserved ejection fraction (HFpEF). The research...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded a $1,380,481 Project Grant to the University of Pittsburgh under the Cardiovascular Diseases Research program (CFDA 93.837) to conduct basic and translational research on indole metabolites as xenobiotic danger signals in acute lung injury. The award, effective September 1, 2025, through May 31, 2029, supports a research program led by a pulmonary and critical care physician investigating the intersection...
The National Heart, Lung, and Blood Institute (NHLBI) awarded Johns Hopkins University a Project Grant of $783,962 (awarded July 15, 2026; completion April 30, 2031) under the Cardiovascular Diseases Research program (CFDA 93.837) to conduct research titled "Clean Air Heart 2: Targeting Indoor Air Quality to Improve Cardiovascular Health in COPD." The project addresses the critical health challenge that individuals with Chronic Obstructive Pulmonary Disease (COPD) face elevated cardiovascular disease risk and mortality rates compared to the general population. The research will investigate indoor air quality (IAQ) as a modifiable intervention target, with particular focus on older adults with COPD who spend over 85% of their time indoors, examining how indoor air pollutants—including particulate matter and ultrafine particles—contribute to adverse cardiovascular outcomes through mechanisms such as impaired autonomic function, endothelial dysfunction, and increased vascular stiffness. This project represents translational research within NHLBI's broader portfolio of cardiovascular and pulmonary disease investigations, which encompasses basic, translational, clinical, and population science across the full spectrum of cardiovascular pathology. The research deliverables will include scientific findings and evidence regarding the relationship between indoor air pollution exposure and cardiovascular health in COPD populations, with results intended to inform future intervention strategies and public health recommendations for this vulnerable population.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $784.0k | 7/14/26 |